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CROSS-PRIMING FOR  A  SECONDARY CYTOTOXIC 
RESPONSE  TO  MINOR H  ANTIGENS WITH 
H-2  CONGENIC  CELLS  WHICH 
DO  NOT  CROSS-REACT IN THE  CYTOTOXIC  ASSAY* 
BY MICHAEL JOHN  BEVAN 
(From The Developmental Biology Laboratory,  The Salk Institute for Biological  Studies, 
San Diego, California 92112) 
Genes  in  the  K  and  D  regions  of the  mouse  major  histocompatibility-2 complex 
(MHC) determine the susceptibility of target cells to lysis by cytotoxic T cells which have 
been immunized to minor (non-H-2 coded) antigens. T cells immunized against trinitro- 
phenyl-modified  (1)  or  virus-infected  (2,  3,  4)  syngeneic  cells,  or  against  the  minor 
histocompatibility (H)  differences  of other  cells  (5,  6,  7),  will  lyse  targets  from  the 
immunizing strain, but not targets from a  congenic strain which carries all the same 
minor information as the immunizing strain but differs at H-2. F1 (BALB/c ×  BALB.B) 
(F,  (C  ×  C.B) H-2 ~lb) mice immunized in vivo and in vitro with C57BL/10  (B10, H-2  b) 
lymphoid cells generate  cytotoxic cells which  are  capable of lysing B10  targets  very 
efficiently, but which do not lyse B10.D2 (H-2 ~) targets (6). 
Such H-2 restriction of cytolysis is almost absolute, there being less than  2%  cross- 
reaction of FI (C  x  C.B) anti-B10 cytotoxic cells on B10.D2 targets. The results reported 
here show that the same H-2 restriction does not apply during the in vivo priming phase 
of the induction. That is, B10 lymphoid cells do prime F~ (C  ×  C.B) mice for an excellent 
secondary in vitro cytotoxic response to B10 and B10.D2 cells (and vice versa). DBA/2 (H- 
2 ~) and B 10. D2 cross-react in the cytotoxic assay, and DBA/2 spleen or thymus cells prime 
F, (C x  C.B) mice very well for a secondary response to DBA/2, B10.D2, and B10. When 
DBA/2 mastocytoma cells are used for priming, however, the H-2 restriction holds true, 
i.e.,  P815  cells prime  for  a  secondary response  to  DBA/2  and  B10.D2,  but  not  for  a 
response to B10.  Means to explain these results either in terms of the altered self or 
interaction antigen hypothesis (1,  3,  5) or in terms of the intimacy or dual recognition 
hypothesis (8) are discussed. 
Materials and Methods 
Mice.  C57BL/1OSn (B10, H-2b), BIO.D2/nSn(H-2d),  and DBA/2  (H-2  d) female mice were pur- 
chased from The Jackson Laboratory, Bar Harbor, Maine. FL (BALB/c x BALB.B) (FI (C x C.B), 
tl-2 ~lb) mice were bred at the Salk Institute. All mice used were female and 8-20-wk old at the start 
of the experiment. 
Immunizations.  In vivo priming injections were of viable allogeneic cells in Hanks' balanced 
salt solution given intraperitoneally. The source and number of cells injected is indicated in the 
text.  In vitro immunizations were done in mixed lymphocyte cultures (MLC)  using spleen as 
source of responder and stimulator cells. Cell concentration, medium, and culture conditions were 
exactly as described previously (6). It should be remembered that under these conditions FI (C × 
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C.B) spleen cells give no detectable primary cytotoxic response to B10,  B10.D2,  or DBA/2 cells. 
Cytotoxic cells immunized across broad non-H-2-coded genetic differences show extensive cross- 
reaction on allogeneic H-2 identical cells (5, 6). Specificity for the immunizing minor H  allele has 
been shown, however, using minor H congenic mice as responders and stimulators (9).  Further- 
more, priming has been shown to be specific also, e.g., B10.LP mice were derived from an initial 
cross between B10 and LP/J(H-2  b) and differ from B10 only in a  portion of chromosome 2 which 
carries H-3 and H-13; B10. LP mice injected once with B10 cells are primed for a secondary cytotoxic 
response to B10,  but are not primed for a response to LP/J. 
Cytotoxic Assay.  Targets were spleen cells which had been cultured for 2 days with 10 ftg/ml 
lipopolysaccharide (Salmonella typhosa, 0901, LPS, B-cell blasts) obtained from Difco Laborato- 
ries, Detroit, Mich. 4 x  104 [5~Cr]sodium chromate-labeled LPS blasts were titered against three or 
fourfold dilutions of the cytotoxic cells for 4 h as described previously (6). Percent specific release of 
5~Cr was calculated as follows: 
experimental release cpm -  spontaneous release cpm  x  100 
total cpm -  spontaneous release cpm 
Results 
Spleen cells from F1 (C x  C.B) mice, which had been injected 5 wk earlier with 
42  ×  106 B10.D2 spleen cells, were cultured in vitro with irradiated spleen cells 
from F1 (C  ×  C.B), B10.D2, or B10 mice or an equal mixture of B10.D2 and B10 
cells.  After 5 days the cultured cells were assayed for lysis of B10.D2 and B10 
LPS blasts. F~ cells boosted with B10.D2 cells lysed B10.D2 targets (Fig. 1 a) but 
not B10 targets (Fig.  1 b). F~ cells boosted with B10 cells lysed B10 targets (Fig. 
l b)  but not  B10.D2 targets  (Fig.  1 a).  There  was  almost no  detectable cross- 
reaction of either population on the two targets in the cytotoxic assay. Unprimed 
F1 cells were not cultured in MLC with irradiated  B10 or B10.D2 cells in this 
experiment,  but on three other occasions this did not give rise to measurable 
cytotoxic effects (see Table I). The activity of the B10.D2-boosted cells was about 
fourfold higher than the B10-boosted cells in this experiment (comparing lysis of 
the  corresponding  targets).  Boosting with a  mixture  of B10 and  B10.D2 cells 
gave activity against both targets  (Fig.  1 a  and b). 
The  results  presented  in  Table  I  show  that  the  kinetics  of generation  of 
cytotoxic cells in MLC was faster when the original priming strain was used for 
the boost than when H-2 congenic cells were used. Spleen cells from normal F1 
(C × C.B) mice or from F~ mice primed with B10 spleen cells were cultured with 
irradiated F1, B10, or B10.D2 cells. The cytotoxicity against B10 and B10.D2 was 
assayed after 3 or 5 days of culture. On day 3 the B10-primed, B10-boosted cells 
lysed B10 targets  significantly,  while  the  B10.D2-boosted cells  lysed neither 
target above the spontaneous release value. By day 5 both populations showed 
cytotoxic activity specific for the targets used for the boost. Activity against the 
original priming strain,  B10, by the B10-boosted cells was about twofold higher 
than  activity against  B10.D2  by the  cross-boosted cells.  The  B10.D2  boosted 
population  lysed B10 targets  weakly,  50-fold less  effectively than  they lysed 
B10.D2 targets.  Normal F1 cells cultured in vitro for 5 days with B10 or B10.D2 
cells did not cause measurable lysis of either target. 
The results so far have shown that cells from two strains which did not cross- 
react  at the  F1 cytotoxic effector level did cross-react strongly during  in vivo 
priming.  There  is  a  situation,  however,  in  which  the H-2  complex restricts 
cytotoxicity and priming.  Cytotoxic cells from BALB/c mice (5) and F~ (C x  C.B) MICHAEL  JOHN  BEVAN  BRIEF  DEFINITIVE  REPORT  1285 
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FIG.  1.  Secondary in vitro cytotoxic response of B10.D2-primed F~ (C × C.B) spleen cells to 
B10.D2 and BI0 cells. Culture period was 5 days. Assayed against [~Cr]LPS blasts from (a) 
B10.D2 and (b) B10. FI cells cultured with irradiated F~ cells (V-V),  B10.D2 cells (O- O), 
B10 cells (D-D), or a 1:1 mixture of B10.D2 and B10 cells (A-A).  Spontaneous release of 
5~Cr was 16.8 and 13.0%. 
TABLE  I 
Kinetics of the Cytotoxic Response of Spleen Cells from BlO-Primed F,(C × C.B) Mice to 
BIO and BIO.D2 Cells 
Responding  Boosted  Aggressor: 
F~(C  x  C.B)  with:  target ratio 
spleen cells* 
Percent specific cytotoxicity after cultures 
Day 3  Day 5 
5JCr-B10  5'Cr-B10.D2  ~Cr-B10  ~Cr-B10.D2 
B10 primed  B10  62:1  11.3  -8.2  59.4  -2.0 
B10 primed  B10  21:1  8,1  -6.6  49.3  -0.7 
B10 primed  B10.D2  62:1  -4.3  -0.5  7.4  54.8 
B10 primed  BI0.D2  21:1  -2.6  -1.5  3.6  38.1 
Normal  B10  124:1  ND  ND  -0.1  - 3.4 
Normal  B10.D2  124:1  ND  ND  -2.1  -  1.1 
* Priming was with 42  ×  10  e B10 spleen cells. 
S Spontaneous release from the {'~Cr]LPS blasts varied from 13.4  to 20.0%. 
mice  (Bevan,  unpublished)  immunized  only  with  P815  (DBA/2)  mastocytes 
cross-reacted on B10.D2 targets but not on B10 targets.  Spleen cells from F~ mice 
injected  either  with  50  ×  106  B10  spleen  cells  or  with  107  P815  cells  were 
stimulated  in MLC  with B10,  DBA/2,  or B10.D2  spleen cells and assayed  5 days 
later  for  lysis  of LPS  blasts  from  the  three  strains.  The  results  with  B10  and 1286  MICHAEL  JOHN  BEVAN  BRIEF  DEFINITIVE  REPORT 
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FIG.  2.  Mastocytoma  cells  fail to  cross-prime  for a  secondary cytotoxic  response to H-2 
different cells. Spleen cells from F~  (C  x  C.B) mice which had been primed either with B10 
spleen cells (open symbols) or with DBA/2 mastocytes P815 (closed symbols) were cultured 
in MLC for 5 days with irradiated spleen cells from B10 (O and @), B10.D2 (n,  III), or DBA/ 
2,  (A,  &).  Assayed for lysis of LPS blasts from (a) B10 and (b) B10.D2 mice.  Spontaneous 
release of~Cr was 16.0 and 12.1%. The assay on DBA/2 targets was almost identical to the 
assay on B10.D2 targets. 
B10.D2  target cells are shown in Fig.  2.  The F1  mice injected with B10 spleen 
cells were primed for a secondary cyctotoxic response to B10 (Fig. 2 a) and for a 
response to B10. D2 (approximately threefold weaker) which could also be stimu- 
lated by DBA/2 spleen cells (Fig. 2 b).  However, while the P815-primed F1 cells 
gave  an  excellent  cytotoxic  response  to  B10.D2  or  DBA/2  (Fig.  2b)  they  re- 
sponded very poorly to B10 cells. In a separate experiment P815-primed F1 cells 
gave 39% lysis of B10.D2 targets at a ratio of 1.5:1 after boosting with B10.D2, 
but only 2.9% lysis of B10 targets at a ratio of 120:1 after boosting with B10 cells. 
In the experiment shown in Fig.  2,  the pattern  of lysis of DBA/2  targets was 
almost  identical  with  that  of  B10.D2  targets  (data  not  shown).  In  another 
experiment it was found that F~  (C  x  C.B)  mice primed 5 wk earlier with 10  ? 
spleen or thymus cells from DBA/2 were able to mount an excellent secondary 
cytotoxic response to DBA/2,  B10.D2,  and B10. 
Discussion 
The finding that the same minor H  alleles on H-2 different congenic cells do 
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previous work on the rejection of transplants in vivo. Thus Snell's immunization 
test  for  typing  minor  H  alleles  assumes  cross-reaction  in  priming  (10);  the 
rejection of syngeneic male tissue by female mice can be tolerized or speeded up 
by exposure  to  male  tissue  of a  different  H-2  type  (11);  finally,  F1  specific 
antigens  have  not  been  detected  in  skin  graft  rejection  (12),  although  the 
cytotoxic assay apparently detects them (5,  6). The work reported here makes 
the in vivo and in vitro phenomena more compatible by showing that although 
F,  (C  x  C.B) cytotoxic effector cells detect no cross-reaction between B10 and 
B10.D2,  there  is  a  high  degree  of cross-reaction  in  priming  for  a  secondary 
cytotoxic response. 
The  altered  self or interaction  antigen  hypothesis  states that  the  minor  H 
antigens  which  F1  cytotoxic cells recognize  on  B10 and  B10.D2  are  noncross- 
reactive because in B10 they are modified by H-2 b genes and in B10.D2 by H-2 d 
genes (5, 6). To preserve this idea intact while explaining the cross-priming with 
B10 and B10.D2, one can postulate the following: (a) Precursor cytotoxic T cells 
require helper T cells to respond. The determinants recognized by the F1 helper 
cells are different from those recognized by cytotoxic cells,  and they do cross- 
react strongly between B10 and B10.D2 lymphoid cells. (b) Expanding the pool 
of F1 helper cells by priming with B10 is sufficient to give a secondary cytotoxic 
response to B10.D2.  This  is analogous to carrier  priming  resulting  in an  en- 
hanced  B-cell response  to  a  hapten  coupled to  the  carrier.  This  explanation 
predicts that in a  B10-primed F, animal there is an expanded pool of cytotoxic 
cells reactive to B10, but not an expanded cytotoxic pool reactive with B10.D2. 
The dual recognition or intimacy hypothesis states that the minor H antigens 
of B10 and B10.D2 are the same, but T-cell lysis requires a  second interaction 
between killer  and  target  which  is controlled by H-2.  This  hypothesis might 
predict that  an injection of B10 cells does expand the pool of F1 cytotoxic cells 
reactive  with  B10.D2,  but  that  they  cannot  express  their  lytic  function  on 
B10.D2 until they are confronted with B10.D2 cells for at least 2 days. 
Using viable P815 tumor cells to prime F, mice, however, does demonstrate H- 
2  restriction,  i.e.,  whereas  DBA/2  spleen  or  thymus  cells  cross-prime  for  a 
secondary response to B10,  DBA/2 mastocytes do not (Fig.  2).  T-cell-mediated 
cytotoxicity is restricted by the K  and D regions of H-2  (1, 2, 6, 7); helper T-cell 
function, on the other hand, is restricted by the/region of H-2 (8). Helper T cells 
may recognize minor antigens  in association with/-region  products,  and it is 
possible that I b and I ~ products cross-react.  Spleen and thymus cells express I- 
region genes,  but there is no evidence that  mastocytes do. This  could explain 
why mastocytes fail to cross-prime. Another possible explanation for the differ- 
ence between normal cells and tumor cells during priming is simply that, unlike 
normal  cells,  the  injected tumor cells grow rapidly for at least  7 days before 
succumbing  to  the  host  immune  response.  Such  a  great  antigenic  stimulus 
might  bypass the normal  induction  pathways  (e.g.,  host macrophages)  which 
are followed when nongrowing cells are used to prime. 
Summary 
Cytotoxic effector T cells of F1 (BALB/c x  BALB.B) (H-2 '~1~) mice immunized 
against  the  minor  histocompatibility  differences of C57BL/10  (H-2 b)  can lyse 1288  MICHAEL  JOHN  BEVAN  BRIEF  DEFINITIVE  REPORT 
targets from C57BL/10, but cannot lyse B10.D2 (H-2 d) targets. Despite this lack 
of cross-reaction in the cytotoxic assay, C57BL/10 cells do prime F,  (BALB/c  × 
BALB.B) mice for a  secondary cytotoxic response to B10.D2.  C57BL/10-primed, 
B10.D2-boosted  cytotoxic cells  lyse  B10.D2  targets  but  not  C57BL/10  targets. 
DBA/2 (H-2 ~) spleen cells or thymocytes prime F~ mice for a secondary response 
to  DBA/2,  B10.D2,  and  C57BL/10  cells,  but  DBA/2  mastocytes,  P815,  do  not 
prime for a response to C57BL/10.  Whether H-2 congenic lymphoid cells express 
minor histocompatibility determinants which cross-react at the cytotoxic T-cell 
level or the helper T-cell level is discussed. 
I thank R. E. Langman for discussion. 
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